Search

icostatistics

E. Ikdahl

Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases
Discrepancies in risk age and relative risk estimations of cardiovascular disease in patients with inflammatory joint diseases
Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: Experiences from the nationwide NOCAR project
Cardiovascular disease risk profiles in inflammatory joint disease entities
Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases
Predictive value of arterial stiffness and subclinical carotid atherosclerosis for cardiovascular disease in patients with rheumatoid arthritis
Sustained improvement of arterial stiffness and blood pressure after long-term rosuvastatin treatment in patients with inflammatory joint diseases: Results from the rora-as study
EULAR task force recommendations on annual cardiovascular risk assessment for patients with rheumatoid arthritis: An audit of the success of implementation in a rheumatology outpatient clinic
Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: Results from the RORA-AS statin intervention study
Rosuvastatin-induced carotid plaque regression in patients with inflammatory joint diseases: The rosuvastatin in rheumatoid arthritis, ankylosing spondylitis and other inflammatory joint diseases study

Powered by the Academic theme for Hugo.